Zobrazeno 1 - 10 of 24 pro vyhledávání: '"Silas, Martin"'
1
Akademický článek
Bis[2-(isoquinolin-1-yl)phenyl-κ2N,C1](2-phenyl-1H-imidazo[4,5-f][1,10]phenanthroline-κ2N,N′)iridium(III) hexafluoridophosphate methanol monosolvate
Autor: Silas Martin, William W. Brennessel, Ammar Hasan, Carly R. Reed
Publikováno v: IUCrData, Vol 9, Iss 9, p x240859 (2024)
The title compound, [Ir(C15H10N)2(C19H12N4)]PF6·CH3OH, crystallizes in the C2/c space group with one monocationic iridium complex, one hexafluoridophosphate anion, and one methanol solvent molecule of crystallization in the asymmetric unit, all in g
Externí odkaz: https://doaj.org/article/1e88c126f98743529a0842576943dcd3
Zobrazit plný text záznamu
3
Akademický článek
The impact of non-medical switching among ambulatory patients: an updated systematic literature review
Autor: Erin R. Weeda, Elaine Nguyen, Silas Martin, Michael Ingham, Diana M. Sobieraj, Brahim K. Bookhart, Craig I. Coleman
Publikováno v: Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Background: Non-medical switching (NMS) is defined as switching to a clinically similar but chemically distinct medication for reasons apart from lack of effectiveness, tolerability or adherence. Objective: To update a prior systematic review evaluat
Externí odkaz: https://doaj.org/article/5fc31731938240c2a82c96d93a07b6b2
Zobrazit plný text záznamu
5
The impact of non-medical switching among ambulatory patients: an updated systematic literature review
Autor: Brahim Bookhart, Erin R. Weeda, Silas Martin, Michael Ingham, Diana M Sobieraj, Craig I Coleman, Elaine Nguyen
Publikováno v: Journal of Market Access & Health Policy
Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Background: Non-medical switching (NMS) is defined as switching to a clinically similar but chemically distinct medication for reasons apart from lack of effectiveness, tolerability or adherence. Objective: To update a prior systematic review evaluat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c202f87da3318f554ab8365f2b2cee
https://pubmed.ncbi.nlm.nih.gov/31692904
Zobrazit plný text záznamu
6
CMS hospital readmission reduction program and anticoagulants received following a total hip and knee arthroplasty discharge
Autor: Willy Wynant, Craig I Coleman, Yongling Xiao, François Laliberté, Silas Martin, Patrick Lefebvre, Brahim Bookhart, Scott Kaatz, Jeff Schein
Publikováno v: Current medical research and opinion. 34(11)
Objectives: To assess association between 30 day readmission rate and treatment received after total hip and knee arthroplasty (THA/TKA) discharge (rivaroxaban vs. warfarin or non-anticoagulant). To subsequently model impact of increasing rivaroxaban
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e584a8e7878b8a8519f8c768eb209d2e
https://pubmed.ncbi.nlm.nih.gov/29749269
Zobrazit plný text záznamu
7
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure
Autor: Concetta Crivera, Steven Deitelzweig, Colleen A. McHorney, François Laliberté, Patrick Lefebvre, Brahim Bookhart, Guillaume Germain, Winnie W. Nelson, Jeffrey Schein, Silas Martin
Publikováno v: Current Medical Research and Opinion. 31:2167-2173
CMS Star Ratings help inform beneficiaries about the performance of health and drug plans. Medication adherence is currently weighted at nearly half of a Part D plan's Star Ratings. Including the adherence to non-vitamin-K-antagonist oral anticoagula
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6f9a55e0890a42fd0f2235d7eba4bc
https://doi.org/10.1185/03007995.2015.1096242
Zobrazit plný text záznamu
8
Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control
Autor: Silas Martin, Robert A. Bailey, Patrick Lefebvre, Amanda Melina Grittner, Jonathan Gravel, Marie-Hélène Lafeuille, Lawrence Garber, Mei Sheng Duh
Publikováno v: Journal of Medical Economics. 18:113-125
This study examines the association between changes in diabetes-related quality measures (QMs) (HbA1c, systolic and diastolic blood pressure [BP], low-density lipoprotein cholesterol [LDL-C], and body weight) and healthcare costs in Type 2 diabetes m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab4bbb2d6253b58a5d26e07402938a58
https://doi.org/10.3111/13696998.2014.980503
Zobrazit plný text záznamu
9
Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012)
Autor: Alex Ward, Silas Martin, Piedad Alvarez, Lien Vo
Publikováno v: Journal of Medical Economics. 17:176-183
To estimate the direct medical costs associated with managing complications, hypoglycemia episodes, and infections associated with type 2 diabetes expressed in 2012 United States dollars (USD).Direct data analysis and microcosting were used to estima
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54e08a1b33faa5948e4859bc1ccab268
https://doi.org/10.3111/13696998.2014.882843
Zobrazit plný text záznamu
10
Cost-effectiveness of combination therapy with etravirine in treatment-experienced adults with HIV-1 infection
Autor: Sandra E. Talbird, Silas Martin, Josephine Mauskopf, Anita Brogan
Publikováno v: AIDS. 26:355-364
Objective To assess the cost-effectiveness of etravirine (INTELENCE), a novel nonnucleoside reverse transcriptase inhibitor, used in combination with a background regimen that included darunavir/ritonavir, from a Canadian Provincial Ministry of Healt
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e2b606dd723e99baae7bb4c585ae253
https://doi.org/10.1097/qad.0b013e32834e87e6
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje